Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-030621
Date:2020-05-18
Issuer: AKCEA THERAPEUTICS, INC. (AKCA)
Original Submission Date:

Reporting Person:

PRICE MICHAEL DENNIS
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-05-18 A 50,000 a $0.00 50,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 14.78 2020-05-18 deemed execution date A 300,000 (a) 2030-05-17 common stock 300,000 $14.78 300,000 direct
Footnotes
IDfootnote
f1 represents restricted stock unit award granted under the issuer's 2015 equity incentive plan.
f2 the shares vest as follows: 1/4th of the shares vest one year after may 18, 2020; 1/48th of the shares vest monthly thereafter over the next three years.
WhaleWisdom Logo

Elevate your investments